FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Info on DTC Advertising Survey Sent to OMB

08/04/2016

Federal Register Notice: FDA has submitted a proposed collection of information entitled, “National Direct-to-Consumer Adver...

Comments Sought on FOIA Certification

08/04/2016

Federal Register Notice: FDA is seeking public comment on a proposed collection of information on “Certification of Identity...

Guidance on Compounding Facilities Insanitary Conditions

08/04/2016

Federal Register Notice: FDA is making available a draft guidance for industry entitled Insanitary Conditions at Compounding Facil...

FDA Posts List of Approved PMAs

08/04/2016

Federal Register Notice: FDA is publishing a list of premarket approval applications (PMAs) that have been approved. This list inc...

FDA Posts Animal Drug User Fee Rates

07/28/2016

Federal Register Notice: FDA is announcing the rates and payment procedures for fiscal year 2017 animal drug user fees: $350,700 f...

FDA Posts Generic Animal Drug User Fees for FY 2017

07/28/2016

Federal Register Notice: FDA is announcing the fee rates and payment procedures for fiscal year 2017 generic new animal drug user ...

Docket Established for Reducing HIV Risk for Blood Donors

07/28/2016

Federal Register Notice: FDA is establishing a public docket for comment on the agency’s blood donor deferral recommendation...

Prescription Drug User Fee Rates Posted

07/28/2016

Federal Register Notice: FDA is announcing the rates for prescription drug user fees for fiscal year 2017: for an application requ...

FDA Posts Biosimilar User Fee Rates

07/28/2016

Federal Register Notice: FDA is announcing the rates for biosimilar user fees for fiscal year 2017. Under the Biosimilar User Fee ...

Comments Sought on Device Pre-Submission Program

07/28/2016

Federal Register Notice: FDA is seeking public comment on requests for feedback submitted under the Pre-Submission program for med...